No one should face cancer alone. Obviously, researchers and physicians are necessary to diagnose and treat the illness, and oncology nurses and navigators can guide people through the continuum of ...

Growing evidence suggests that personalized vaccines may help prevent cancer recurrence. To create a customized cancer vaccine, scientists genetically sequence a patient’s tumor and identify ...

Combining standard adjuvant chemotherapy with the immune checkpoint inhibitor atezolizumab [Tecentriq] leads to a significant improvement in disease-free survival in a subset of patients with Stage ...

Wearing frozen or tight-fitting gloves during chemotherapy may help prevent painful peripheral neuropathy. Chemotherapy is effective for many types of cancer, but the medications can harm normal cells ...

Pregnant women who contract COVID-19 are more likely to become severely ill and to be hospitalized than women who aren’t pregnant.

A structured exercise program after surgery for colon cancer was associated with a reduced risk of disease recurrence and improved survival, according to results from a randomized trial presented at ...

A top colorectal cancer doc at the University of Colorado shares insights into AI’s many pearls — and potential pitfalls.

A new study by researchers at the American Cancer Society (ACS) shows that a higher county-level share of medical debt in collections was associated with delays in treatment initiation among ...

A new study found cancer-causing chemicals in lotions, cleaners and other beauty products primarily marketed to and used by Black and Latina women, according to a news release from Silent Spring ...

Cuts to the National Institutes of Health: The Trump administration has cut $2.3 billion in new grant funding since its term began, as well as terminated existing grants on a wide range of topics — ...

Chemotherapy doesn’t just kill cancer cells. It also affects the microbes in the digestive tract. Researchers at UC San Francisco have discovered that some gut bacteria can reduce the side effects of ...

Results from the Phase III SERENA-6 clinical trial found that switching to treatment with camizestrant if an ESR1 mutation is detected during first-line treatment can help slow cancer growth for ...